keyboard_arrow_up

Proteomics Market worth $20,696.4 Million by 2018

The “Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Global Forecast to 2018", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and the Rest of the World (RoW)

 

Browse 138 market data tables, 49 figures spread through 415 pages and in-depth TOC on “Proteomics Market 

http://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html

 

Early buyers will receive 10% customization on this report.

This report studies the global proteomics market, with forecasts to 2018.

The proteomics market has experienced significant growth in the past few years, mainly due to the increasing need of proteomic outcomes in diagnosis, drug discovery, and various applicable advancements in technologies needed to perform proteomic services. Factors that are expected to propel the market growth include the increase in demand for personalized medicine, growing research and development expenditure, technological advancements, and increased funding for proteomics-based projects. However, factors such as the reduction in funding owing to the sequestration cuts in the U.S., difficulties faced by proteomics companies to gain regulatory approvals for biomarkers, high costs of proteomic tools, and dearth of qualified researchers are restraining the growth of this market to a certain extent.

Talk to Our Research Analysts for More Info@

http://www.marketsandmarkets.com/speaktoanalyst.asp?id=731

The global proteomics market is segmented based on instrument technology type, reagents, services, and by geographic regions and by country. The market was valued at $10,223.0 million in 2013 and is expected to grow at a healthy CAGR from 2013 to 2018.

North America accounted for a major share of around 40% of the global proteomics market in 2013, closely followed by Europe. The growth in pharmaceutical and biotechnology R&D expenditure; technological advancements such as high throughput, enhanced sensitivity, and high resolution in proteomics; availability of government and private funding; and the rising demand for proteomics technology in personalized medicine are the factors that are responsible for the large market shares of these regions.

Get The Sample Copy Of This Report:

http://www.marketsandmarkets.com/requestsample.asp?id=731

 

The major players in the global proteomics market are Thermo Fisher Scientific Corporation (U.S.), Agilent Technologies (U.S.), Luminex Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), and Danaher Corporation (U.S.), among others.

 

Browse related reports

 

Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018

 

http://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html

 

 

Mass Spectrometry Market - by Technology (Tandem LC - MS/ Quadrupole/ ICP - MS/ Gas Chromatography - MS/ TOF - MS/ MALDI -TOF/ Fourier Transform - MS) & by Application (Pharmaceutical/ Biotechnology/ Environment/ Food & Beverages) - Global Trends & Forecast to 2018

 

http://www.marketsandmarkets.com/Market-Reports/mass-spectrometry-market-437.html

 

                                                                                                                                                                

About MarketsandMarkets:

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

 

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

 

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

 

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

 

Contact:
Mr. Rohan

Unit No. 802, 8th Floor, 

Tower - 7, Magarpatta City SEZ,

Hadapsar, Pune – 411013, 

Maharashtra, India.

Tel: +1-888-6006-441.
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets